On March 17, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company has broad commercial reach extending across approximately 100 countries and is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team. Learn more about this exciting combination at www.Actavis.com.
What We Treat
Together with the doctors we serve, we strive to understand patients as individuals seeking to live fulfilled lives, express themselves, and fully experience all the world has to offer.
Allergan's portfolio of products includes some of the most inventive medicines, devices, and procedures in the world. These products empower choice for medical specialists and their patients in a variety of specialty areas to meet a diverse set of needs.
Eye diseases like glaucoma and dry eye impact the sight of millions of people each year. Neurologic disorders like cervical dystonia impair functioning and subject sufferers to chronic pain that can narrow and constrain their daily lives. Chronic conditions like psoriasis or hyperhidrosis are difficult diseases to live with, both physically and emotionally. Many of our products and medical devices are aimed at addressing these and similar conditions — some well known and widespread, others rare and frequently misdiagnosed due to lack of awareness. All, however, threaten patients' quality of life and present treatment challenges that we are focused on overcoming.
From our therapeutic origins, we have also evolved into a leader in meeting the unique needs of patients in the areas of facial and breast aesthetics. Allergan's Total Rejuvenation™ portfolio is where science and aesthetics meet, offering the industry's most comprehensive, science-based aesthetic product offering. Each patient who seeks rejuvenation and renewal does so for highly personal reasons, with individual goals for treatment. For these patients, we offer FDA-approved products for glabellar lines (vertical frown lines between the brows that often look like an "11"), facial wrinkle and folds ("parenthesis" around the mouth), general skin care, and breast augmentation or reconstruction.